Global Recombinant Immunotherapeutics Market Research Report 2021

August 2016 | 100 pages | ID: G79B9985523EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant Immunotherapeutics

Revenue, means the sales value of Recombinant Immunotherapeutics

This report studies Recombinant Immunotherapeutics in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Amgen
• AstraZeneca
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifols
• Ferring
• Janssen
• NeuroDerm
• Octapharma
• Roche
• Rhythm Metabolic
• scPharmceuticals
• SteadyMed
• Takeda
• United Therapeutics
• UCB
• US Worldmeds

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Recombinant Immunotherapeutics in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Recombinant Immunotherapeutics in each application, can be divided into

• Medical care
• Hospital
• Application 3

Contents

Global Recombinant Immunotherapeutics Market Research Report 2021

1 RECOMBINANT IMMUNOTHERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Recombinant Immunotherapeutics
1.2 Recombinant Immunotherapeutics Segment by Types
  1.2.1 Global Sales Market Share of Recombinant Immunotherapeutics by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Recombinant Immunotherapeutics Segment by Applications
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 Recombinant Immunotherapeutics Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Recombinant Immunotherapeutics (2011-2021)
  1.5.1 Global Recombinant Immunotherapeutics Sales and Revenue (2011-2021)
  1.5.2 Global Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  1.5.3 Global Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)

2 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Recombinant Immunotherapeutics Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Recombinant Immunotherapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Recombinant Immunotherapeutics Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS ANALYSIS BY REGION

3.1 Global Recombinant Immunotherapeutics Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Recombinant Immunotherapeutics Sales Market Share by Region (2011-2021)
  3.1.2 Global Recombinant Immunotherapeutics Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  3.2.2 North America Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  3.4.2 China Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  3.6.2 India Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS ANALYSIS BY TYPE

4.1 Global Recombinant Immunotherapeutics Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Recombinant Immunotherapeutics Sales and Market Share by Type (2011-2021)
  4.1.2 Global Recombinant Immunotherapeutics Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Sales, Revenue, Price and Growth (2011-2020)
4.3 Type II Sales, Revenue, Price and Growth (2011-2020)
4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS MARKET ANALYSIS BY APPLICATION

5.1 Global Recombinant Immunotherapeutics Sales and Market Share by Application (2011-2021)
5.2 Major Regions Recombinant Immunotherapeutics Sales by Application in 2015 and 2016
  5.2.1 North America Recombinant Immunotherapeutics Sales by Application
  5.2.2 Europe Recombinant Immunotherapeutics Sales by Application
  5.2.3 China Recombinant Immunotherapeutics Sales by Application
  5.2.4 Japan Recombinant Immunotherapeutics Sales by Application
  5.2.5 India Recombinant Immunotherapeutics Sales by Application
  5.2.6 Southeast Asia Recombinant Immunotherapeutics Sales by Application

6 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS MANUFACTURERS ANALYSIS

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Immunotherapeutics Product Overview
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Amgen (2015 and 2016)
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Recombinant Immunotherapeutics Product Overview
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Recombinant Immunotherapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
6.3 Baxter
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Recombinant Immunotherapeutics Product Overview
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Baxter (2015 and 2016)
6.4 Britannia
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Recombinant Immunotherapeutics Product Overview
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Britannia (2015 and 2016)
6.5 Capricor
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Recombinant Immunotherapeutics Product Overview
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Capricor (2015 and 2016)
6.6 CSL Behring
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Recombinant Immunotherapeutics Product Overview
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Recombinant Immunotherapeutics Sales, Revenue, Price of CSL Behring (2015 and 2016)
6.7 GlaxoSmithKline
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Recombinant Immunotherapeutics Product Overview
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Recombinant Immunotherapeutics Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
6.8 Grifols
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Recombinant Immunotherapeutics Product Overview
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Grifols (2015 and 2016)
6.9 Ferring
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Recombinant Immunotherapeutics Product Overview
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Ferring (2015 and 2016)
6.10 Janssen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Recombinant Immunotherapeutics Product Overview
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Janssen (2015 and 2016)
6.11 NeuroDerm
6.12 Octapharma
6.13 Roche
6.14 Rhythm Metabolic
6.15 scPharmceuticals
6.16 SteadyMed
6.17 Takeda
6.18 United Therapeutics
6.19 UCB
6.20 US Worldmeds

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Immunotherapeutics
Figure Global Sales Market Share of Recombinant Immunotherapeutics by Type in 2015
Table Recombinant Immunotherapeutics Product Type of by Manufacturers
Table Recombinant Immunotherapeutics Sales Market Share by Application in 2015 and 2016
Figure North America Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure China Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure India Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Table Global Recombinant Immunotherapeutics Sales and Revenue (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure Global Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Table Global Recombinant Immunotherapeutics Sales of Key Manufacturers (2015 and 2016)
Table Global Recombinant Immunotherapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Immunotherapeutics Sales Share by Manufacturers
Figure 2016 Recombinant Immunotherapeutics Sales Share by Manufacturers
Table Global Recombinant Immunotherapeutics Revenue by Manufacturers (2015 and 2016)
Table Global Recombinant Immunotherapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Recombinant Immunotherapeutics Revenue Share by Manufacturers
Table 2016 Global Recombinant Immunotherapeutics Revenue Share by Manufacturers
Table Manufacturers Recombinant Immunotherapeutics Manufacturing Base Distribution and Product Type
Table Global Recombinant Immunotherapeutics Sales Market by Region (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Market by Region (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Market Share by Region (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue Market by Region (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue Market Share by Region (2011-2021)
Table North America Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure North America Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Europe Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure Europe Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
Table China Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure China Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Japan Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure Japan Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
Table India Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure India Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Recombinant Immunotherapeutics Sales, Revenue and Growth Rate (2011-2021)
Table Global Recombinant Immunotherapeutics Sales by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Sales Share by Type (2011-2021)
Figure Sales Market Share of Recombinant Immunotherapeutics by Type (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Growth Rate by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue Share by Type (2011-2021)
Figure Global Recombinant Immunotherapeutics Revenue Growth Rate by Type (2011-2021)
Figure Type I Sales, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Sales, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Sales, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Recombinant Immunotherapeutics Sales by Application (2011-2021)
Table Global Recombinant Immunotherapeutics Sales Market Share by Application (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Market Share by Application in 2015
Figure Global Recombinant Immunotherapeutics Sales Market Share by Application in 2021
Table North America Recombinant Immunotherapeutics Sales by Application (2015 and 2016)
Table Europe Recombinant Immunotherapeutics Sales by Application (2015 and 2016)
Table China Recombinant Immunotherapeutics Sales by Application (2015 and 2016)
Table Japan Recombinant Immunotherapeutics Sales by Application (2015 and 2016)
Table India Recombinant Immunotherapeutics Sales by Application (2015 and 2016)
Table Southeast Asia Recombinant Immunotherapeutics Sales by Application (2015 and 2016)
Table Global Recombinant Immunotherapeutics Sales Growth Rate by Application (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Growth Rate by Application (2011-2021)
Table Amgen Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of US Worldmeds (2015 and 2016)